Primary |
Schizophrenia |
24.6% |
Psychotic Disorder |
15.8% |
Depression |
13.8% |
Bipolar Disorder |
9.2% |
Anxiety |
4.2% |
Schizoaffective Disorder |
4.0% |
Schizophrenia, Paranoid Type |
4.0% |
Bipolar I Disorder |
2.9% |
Mental Disorder |
2.9% |
Hallucination |
2.5% |
Post-traumatic Stress Disorder |
2.2% |
Agitation |
2.0% |
Insomnia |
2.0% |
Sleep Disorder |
1.8% |
Major Depression |
1.6% |
Bipolar Ii Disorder |
1.3% |
Diabetes Mellitus |
1.3% |
Hypertension |
1.3% |
Obsessive-compulsive Disorder |
1.3% |
Attention Deficit/hyperactivity Disorder |
1.1% |
|
Weight Increased |
10.3% |
Tremor |
9.0% |
Suicidal Ideation |
8.4% |
Weight Decreased |
7.7% |
Somnolence |
7.1% |
Obsessive-compulsive Disorder |
6.5% |
Suicide Attempt |
6.5% |
Parkinsonism |
5.8% |
Migraine |
3.9% |
Swollen Tongue |
3.9% |
Withdrawal Syndrome |
3.9% |
Death |
3.2% |
Electrocardiogram Qt Prolonged |
3.2% |
Hearing Impaired |
3.2% |
Psychotic Disorder |
3.2% |
Sedation |
3.2% |
Visual Impairment |
3.2% |
Epilepsy |
2.6% |
Hypotension |
2.6% |
Muscle Spasms |
2.6% |
|
Secondary |
Mental Disorder |
15.1% |
Schizophrenia |
14.2% |
Psychotic Disorder |
13.0% |
Depression |
9.3% |
Hallucination |
7.8% |
Hallucination, Auditory |
5.6% |
Post-traumatic Stress Disorder |
5.6% |
Tooth Infection |
5.6% |
Anxiety |
4.4% |
Bipolar Disorder |
3.9% |
Schizoaffective Disorder |
3.4% |
Dissociative Disorder |
3.0% |
Product Used For Unknown Indication |
1.9% |
Drug Use For Unknown Indication |
1.5% |
Insomnia |
1.2% |
Delusion |
1.0% |
Generalised Anxiety Disorder |
1.0% |
Diabetes Mellitus |
0.8% |
Hypothyroidism |
0.8% |
Major Depression |
0.8% |
|
Weight Increased |
25.5% |
Unresponsive To Stimuli |
8.5% |
Withdrawal Syndrome |
7.2% |
Insomnia |
5.2% |
Suicidal Ideation |
5.2% |
Tooth Infection |
5.2% |
Somnolence |
4.6% |
Suicide Attempt |
4.6% |
Agitation |
3.9% |
Swollen Tongue |
3.9% |
Tachycardia |
3.9% |
Disturbance In Attention |
3.3% |
Weight Decreased |
3.3% |
Electrocardiogram Qt Prolonged |
2.6% |
Psychotic Disorder |
2.6% |
Self Esteem Decreased |
2.6% |
Dyskinesia |
2.0% |
Scar |
2.0% |
Tremor |
2.0% |
Urinary Incontinence |
2.0% |
|
Concomitant |
Schizophrenia |
14.1% |
Product Used For Unknown Indication |
13.0% |
Schizoaffective Disorder |
13.0% |
Depression |
10.2% |
Drug Use For Unknown Indication |
10.2% |
Anxiety |
5.6% |
Attention Deficit/hyperactivity Disorder |
3.4% |
Bipolar Disorder |
3.4% |
Psychotic Disorder |
3.4% |
Sleep Disorder |
3.4% |
Epilepsy |
2.8% |
Hypersensitivity |
2.8% |
Insomnia |
2.8% |
Agitation |
2.3% |
Rheumatoid Arthritis |
2.3% |
Schizophrenia, Paranoid Type |
2.3% |
Mental Disorder |
1.7% |
Alcoholism |
1.1% |
Delusion |
1.1% |
Hypothyroidism |
1.1% |
|
Weight Increased |
26.4% |
Parkinsonism |
7.5% |
Tachycardia |
7.5% |
Anaemia |
3.8% |
Device Failure |
3.8% |
Drug Interaction |
3.8% |
Gamma-glutamyltransferase Increased |
3.8% |
Hepatotoxicity |
3.8% |
Hypersensitivity |
3.8% |
Leukopenia |
3.8% |
Lower Limb Fracture |
3.8% |
Overdose |
3.8% |
Partial Seizures |
3.8% |
Tardive Dyskinesia |
3.8% |
Treatment Noncompliance |
3.8% |
Vitreous Floaters |
3.8% |
Vomiting |
3.8% |
Anxiety |
1.9% |
Eating Disorder |
1.9% |
Electrocardiogram Qt Interval Abnormal |
1.9% |
|
Interacting |
Schizophrenia, Paranoid Type |
25.9% |
Restlessness |
9.3% |
Schizophrenia |
9.3% |
Mania |
7.4% |
Agitation |
5.6% |
Psychotic Disorder |
5.6% |
Bipolar Disorder |
3.7% |
Contraception |
3.7% |
Convulsion Prophylaxis |
3.7% |
Depression |
3.7% |
Hallucination |
3.7% |
Mood Altered |
3.7% |
Paranoia |
3.7% |
Aggression |
1.9% |
Analgesic Therapy |
1.9% |
Anxiety |
1.9% |
Psychotic Behaviour |
1.9% |
Schizophrenia, Disorganised Type |
1.9% |
Tachycardia |
1.9% |
|
Gamma-glutamyltransferase Increased |
26.7% |
Hearing Impaired |
20.0% |
Palpitations |
13.3% |
Tremor |
13.3% |
Dystonia |
6.7% |
Extrapyramidal Disorder |
6.7% |
Hepatic Function Abnormal |
6.7% |
Somnolence |
6.7% |
|